Regeneron energizes biotech stocks

Regeneron shares help lift biotech stocks as the regenerative medicine firm jumps ahead of a FDA meeting on its eye drug VEGF Trap-Eye.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.